Optic glioma in children: A retrospective analysis of 101 cases

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 36, Issue 3, 2013, Pages 287-292

  Varan, Ali ^a   Batu, Abduselam ^a   Cila, Ayşenur ^b   Soylemezoǧlu, Figen ^b   Balc, Serdar ^b   Akalan, Nejat ^b   Zorlu, Faruk ^a   Akyüz, Canan ^a   Kutluk, Tezer ^a   Büyükpamukçu, Münevver ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Department of Radiology ^*  (Turkey)

Author keywords

children; neurofibromatosis type 1; optic glioma; prognosis; treatment

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; PREDNISOLONE; PROCARBAZINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL EVALUATION; CLINICAL FEATURE; EXOPHTHALMOS; FEMALE; HEADACHE; HUMAN; HYPERTENSION; HYPOPITUITARISM; HYPOTHALAMUS; INFANT; INTRACRANIAL HYPERTENSION; LONG TERM CARE; MACROCEPHALY; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS; NYSTAGMUS; OBESITY; OPTIC CHIASM; OPTIC NERVE; OPTIC NERVE GLIOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT REFERRAL; PRESCHOOL CHILD; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEIZURE; SEX RATIO; STRABISMUS; TUMOR LOCALIZATION; VISUAL IMPAIRMENT;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASM STAGING; OPTIC NERVE GLIOMA; PREDNISOLONE; PROCARBAZINE; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; VINCRISTINE;

EID: 84878891051     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3182467efa     Document Type: Article

References (37)

1. Blaney SM, Kun LE, Hunter J, et al. Tumors of the optic pathway. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2006: 833-835.
2. Jahraus CD, Tarbell NJ. Optic pathway gliomas. Pediatr Blood Cancer. 2006;46:586-596.
3. Listernick R, Charrow J, Gutmann DH. Intracranial gliomas in neurofibromatosis type-1. Am J Med Genet. 1999;89:38-44.
4. Czyzyk E, Jozwiak S, Roszkowski M, et al. Optic pathway gliomas in children with and without neurofibromatosis 1. J Child Neurol. 2003;18:471-478.
5. Grill J, Laithier V, Rodriguez D, et al. When do children with optic pathway tumors need treatment? An oncological perspective in 106 patients treated in a single centre. Eur J Pediatr. 2000;159: 692-696.
6. Kortmann RD, Timmermann B, Taylor RE, et al. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part I: treatment modalities of radiation therapy. Strahlenther Onko. 2003;179:509-520.
7. Thiagalingam S, Flaherty M, Billson F, et al. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. Ophthalmology. 2004;111:568-577.
8. Listernick R, Louis DN, Packer RJ, et al. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol. 1997;41:143-149.
9. Rodriguez LA, Edwards MS, Levin VA. Management of hypothalamic gliomas in children. An analysis of 33 cases. Neurosurgery. 1990;26:242-247.
10. Medlock MD, Madsen JR, Barnes PD, et al. Optic chiasm astrocytomas of childhood 1. Long-term follow-up. Pediatr Neurosurg. 1997;27:121-128.
11. Binning MJ, Liu JK, Kestle JRW, et al. Optic pathway gliomas: a review. Neurosurg Focus. 2007;23:E2.
12. Astrup J. Natural history and clinical management of optic pathway glioma. Br J Neurosurg. 2003;17:327-335.
13. Tow SL, Chandela S, Miller NR, et al. Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol. 2003;28:262-270.
14. Opocher E, Kremer LC, Da Dalt L, et al. Prognostic factors for progression of childhood optic pathway glioma: a systematic review. Eur J Cancer. 2006;42:1807-1816.
15. Louis DN, Ohgaki H, Wiestler O, et al. WHO Classification of the Tumours of the Central Nervous System. 4th ed. Lyon: IARC; 2007.
16. Brat DJ, Scheithauer BW, Fuller GN, et al. Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain Pathol. 2007;17:319-324.
17. Khafaga Y, Hassounah M, Kandil A, et al. Optic gliomas: a retrospective analysis of 50 cases. Int J Radiat Oncol Biol Phys. 2003;56:807-812.
18. Ahn Y, Cho BK, Kim SK, et al. Optic pathway glioma: outcome and prognostic factors in a surgical series. Childs Nerv Syst. 2006;22:1136-1142.
19. Wisoff JH, Abbott R, Epstein F. Surgical management of exophytic chiasmatic-hypothalamic tumors of childhood. J Neurosurg. 1990;73:661-667.
20. Chan MY, Foong AP, Heisey DM, et al. Potential prognostic factors of relapse-free survival in childhood optic pathway glioma: a multivariate analysis. Pediatr Neurosurg. 1998;29:23-28.
21. Ceppa EP, Bouffet E, Griebel R, et al. The pilomyxoid astrocytoma and its relationship to pilocytic astrocytoma: report of a case and a critical review of the entity. J Neurooncol. 2007;81:191-196.
22. Chikai K, Ohnishi A, Kato T, et al. Clinico-pathological features of pilomyxoid astrocytoma of the optic pathway. Acta Neuropathol. 2004;108:109-114.
23. Packer RJ, Sutton LN, Bilaniuk LT, et al. Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: an update. Ann Neurol. 1988;23:79-85.
24. Packer RJ, Ater J, Allen J, et al. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive lowgrade gliomas. J Neurosurg. 1997;86:747-754.
25. Mahoney DH Jr, Cohen ME, Friedman HS, et al. Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study. Neuro-oncol. 2000;2:213-220.
26. Gajjar A, Heideman RL, Kovnar EH, et al. Response of pediatric low grade gliomas to chemotherapy. Pediatr Neurosurg. 1993;19:113-120.
27. Laithier V, Grill J, Le Deley MC, et al. Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy-results of the first French prospective study for the French Society of Pediatric Oncology. J Clin Oncol. 2003;21:4572-4578.
28. Moreno L, Bautista F, Ashley S, et al. Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidence. Eur J Cancer. 2010;46:2253-2259.
29. Montgomery AB, Griffin T, Parker RG, et al. Optic nerve glioma: the role of radiation therapy. Cancer. 1977;40:2079-2080.
30. Jenkin D, Angyalfi S, Becker L, et al. Optic glioma in children: surveillance, resection, or irradiation? Int J Radiat Oncol Biol Phys. 1993;25:215-225.
31. Zorlu F, Yildiz F, Gurkaynak M, et al. Radiotherapy in the management of optic pathway gliomas. Turk J Cancer. 2000;30:31-35.
32. Wong JY, Uhl V, Wara WM, et al. Optic gliomas. A reanalysis of the University of California, San Francisco experience. Cancer. 1987;60:1847-1855.
33. Kovalic JJ, Grigsby PW, Shepard MJ, et al. Radiation therapy for gliomas of the optic nerve and chiasm. Int J Radiat Oncol Biol Phys. 1990;18:927-932.
34. Bataini JP, Delanian S, Ponvert D. Chiasmal gliomas: results of irradiation management in 57 patients and review of literature. Int J Radiat Oncol Biol Phys. 1991;21:615-623.
35. Grabenbauer GG, Schuchardt U, Buchfelder M, et al. Radiation therapy of optico-hypothalamic gliomas (OHG)-radiographic response, vision and late toxicity. Radiother Oncol. 2000;54:239-245.
36. Fouladi M, Wallace D, Langston JW, et al. Survival and functional outcome of children with hypothalamic/chiasmatic tumors. Cancer. 2003;97:1084-1092.
37. Nicolin G, Parkin P, Mabbott D, et al. Natural history and outcome of optic pathway gliomas in children. Pediatr Blood Cancer. 2009;53:1231-1237.